Group One Trading’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Buy
162,300
+157,400
+3,212% +$1.99M ﹤0.01% 2173
2025
Q4
$81.3K Sell
4,900
-3,100
-39% -$44.3K ﹤0.01% 5170
2025
Q3
$94.2K Sell
8,000
-140,200
-95% -$1.45M ﹤0.01% 5401
2025
Q2
$1.42M Buy
148,200
+103,700
+233% +$574K ﹤0.01% 2442
2025
Q1
$279K Buy
44,500
+39,500
+790% +$240K ﹤0.01% 3680
2024
Q4
$40.6K Sell
5,000
-600
-11% -$7.43K ﹤0.01% 5207
2024
Q3
$101K Buy
5,600
+1,500
+37% +$21K ﹤0.01% 4166
2024
Q2
$42.2K Sell
4,100
-7,900
-66% -$81.4K ﹤0.01% 4638
2024
Q1
$127K Buy
12,000
+3,800
+46% +$32.3K ﹤0.01% 3935
2023
Q4
$74.9K Buy
8,200
+4,300
+110% +$37K ﹤0.01% 4716
2023
Q3
$40.4K Sell
3,900
-172,200
-98% -$2.36M ﹤0.01% 5300
2023
Q2
$2.52M Buy
176,100
+173,000
+5,581% +$1.99M 0.01% 1493
2023
Q1
$22.1K Buy
+3,100
New +$27.2K ﹤0.01% 5432
2022
Q1
Sell
-100
Closed -$2K 8518
2021
Q4
$2K Buy
+100
New +$2.35K ﹤0.01% 7893

Other funds holding PHAT